Validity of [123I]?-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity
- 25 September 2002
- Vol. 46 (3), 199-205
- https://doi.org/10.1002/syn.10130
Abstract
Recent [123I]β‐CIT single‐photon emission computed tomography (SPECT) studies revealed decreased serotonin transporters (SERT) density in the brain of humans with a history of MDMA (“Ecstasy”) use. However, [123I]β‐CIT SPECT has until now not been validated as a method for detecting such serotonergic lesions. Therefore, the present study was undertaken. Following baseline [123I]β‐CIT SPECT scans, a rhesus monkey was treated with MDMA (5 mg/kg, s.c. twice daily for 4 consecutive days). SPECT studies 4, 10, and 31 days after MDMA treatment revealed decreases in [123I]β‐CIT binding ratios in the SERT‐rich brain region studied (hypothalamic/midbrain region), with SERT density reduced by 39% in this brain region 31 days after treatment. Data obtained with SPECT studies correlated well with SERT density determined with autoradiography after sacrifice of the animal (−34%). In addition, ex vivo [123I]β‐CIT binding studies in rats 1 week after treatment with neurotoxic doses of MDMA (20 mg/kg s.c. twice daily for 4 consecutive days) revealed significant reductions in [123I]β‐CIT binding in SERT‐rich regions (including the hypothalamus) when compared to saline‐treated rats. The combined results of these studies indicate that SPECT imaging of SERT with [123I]β‐CIT can detect changes in SERT density secondary to MDMA‐induced neurotoxicity in the hypothalamic/midbrain region, and possibly other brain regions. Synapse 46:199–205, 2002.Keywords
This publication has 25 references indexed in Scilit:
- Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal RecoveryJournal of Neuroscience, 1999
- [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeysSynapse, 1997
- Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brainNeuropsychopharmacology, 1996
- Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")Journal of Neuroscience, 1995
- Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brainSynapse, 1994
- SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primatesSynapse, 1993
- High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brainSynapse, 1992
- High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissueBrain Research, 1989
- Autoradiography of antidepressant binding sites in the human brain: localization using [3h]imipramine and [3h]paroxetineNeuroscience, 1988
- Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sitesBiological Psychiatry, 1988